Pressor effect of inhaled ergotamine in orthostatic hypotension
- 1 January 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (1) , 89-92
- https://doi.org/10.1016/0002-9149(90)90031-u
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Management of chronic orthostatic hypotensionThe American Journal of Medicine, 1986
- Clinical Pharmacokinetics of Ergotamine in Migraine and Cluster HeadacheClinical Pharmacokinetics, 1985
- Treatment of chronic orthostatic hypotension with ergotamine.Circulation, 1983
- Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunctional statesThe American Journal of Cardiology, 1981
- Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with Orthostatic hypotensionClinical Pharmacology & Therapeutics, 1981
- Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.BMJ, 1980
- Treatment of orthostatic hypotension with dihydroergotamine.BMJ, 1979
- Angina pectoris and sudden death in the absence of atherosclerosis following ergotamine therapy for migraineThe American Journal of Medicine, 1979
- HAEMODYNAMIC EFFECTS OF DIHYDROERGOTAMINE IN PATIENTS WITH POSTURAL HYPOTENSIONActa Medica Scandinavica, 1974
- Effect of caffeine on intestinal absorption of ergotamine in manEuropean Journal of Clinical Pharmacology, 1974